|
[1]
|
Cosentino F, Verma S, Ambery P, Treppendahl MB, van Eickels M, Anker SD, et al. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table. Eur Heart J 2023;44(39):4141 − 56. |
|
[2]
|
Zhao Y, Zhang PH, Lee JT, Oldenburg B, Heusden AV, Haregu TN, et al. The prevalence of metabolic disease multimorbidity and its associations with spending and health outcomes in middle-aged and elderly Chinese adults. Front Public Health 2021;9:658706. |
|
[3]
|
Fan JN, Sun ZJ, Yu CQ, Guo Y, Pei P, Yang L, et al. Multimorbidity patterns and association with mortality in 0. 5 million Chinese adults. Chin Med J (Engl) 2022;135(6):648 − 57. |
|
[4]
|
Deng YY, Ngai FW, Qin J, Yang L, Wong KP, Wang HH, et al. Combined influence of eight lifestyle factors on metabolic syndrome incidence: a prospective cohort study from the MECH-HK study. Nutrients 2024;16(4):547. |
|
[5]
|
Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol 2020;19(4):359 − 66. |
|
[6]
|
Tang X, Liu QG. Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City. BMC Public Health 2018;18(1):707. |
|
[7]
|
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73 − 84. |
|
[8]
|
Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab 2018;27(1):22 − 41. |
|
[9]
|
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 2022;23(2):786. |
|
[10]
|
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142(8):611 − 9. |